Status:
COMPLETED
Feasibility of a New Model for Exercise Prescription in Cystic Fibrosis
Lead Sponsor:
University of Alabama at Birmingham
Conditions:
Cystic Fibrosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this protocol is to begin an exercise program combined with behavioral counseling for patients who are hospitalized with a cystic fibrosis exacerbation. The exercise program will begin ...
Detailed Description
During the hospitalization (T0 to T1; Figure 1, next page), participants will perform supervised exercise 6 days/wk. On each of these days, there will be a 5-10 min warm up consisting of low intensity...
Eligibility Criteria
Inclusion
- Confirmed diagnosis of CF
- 18 years old or older
- Current pulmonary exacerbation with planned UAB hospitalization for at least 10 days
- Willing to participate in a regular, ongoing exercise program
- Access to broadband internet
Exclusion
- Currently exercising more than 60 min/week
- Massive hemoptysis or pneumothorax in past 3 months
- Neuromusculoskeletal impairments that preclude exercise
Key Trial Info
Start Date :
December 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 10 2025
Estimated Enrollment :
3 Patients enrolled
Trial Details
Trial ID
NCT04075864
Start Date
December 1 2020
End Date
December 10 2025
Last Update
December 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alabama at Birmingham
Birmingham, Alabama, United States, 35233